| Literature DB >> 25248916 |
Marlous van Laar, Daniel P Stark, Patricia McKinney, Roger C Parslow, Sally E Kinsey, Susan V Picton, Richard G Feltbower1.
Abstract
BACKGROUND: Little aetiological epidemiological research has been undertaken for major cancers occurring in teenagers and young adults (TYA). Population mixing, as a possible proxy for infectious exposure, has been well researched for childhood malignancies. We aimed to investigate effects of population mixing in this older age group using an English national cancer dataset.Entities:
Mesh:
Year: 2014 PMID: 25248916 PMCID: PMC4180542 DOI: 10.1186/1471-2407-14-698
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Leukaemia, lymphoma and CNS tumours amongst teenagers and young adults in England, 1996-2005
| Diagnostic group a | Cases (subgroup%) | Incidence rate (per 10 6person-years) |
|---|---|---|
|
| ||
|
| 591 (45%) | 9.7 |
|
| 463 (36%) | 7.6 |
|
| 147 (11%) | 2.4 |
|
| 98 (8%) | 1.6 |
|
|
|
|
|
| ||
|
| 991 (32%) | 16.3 |
|
| 2079 (68%) | 34.1 |
|
|
|
|
|
| ||
|
| 629 (33%) | 10.3 |
|
| 195 (10%) | 3.2 |
|
| 99 (5%) | 1.6 |
|
| 111 (6%) | 1.8 |
|
| 702 (37%) | 11.5 |
|
| 146 (8%) | 2.4 |
|
|
|
|
|
|
|
|
aDefined according to the Birch Teenage and Young Adult Classification Scheme [24].
Abbreviation: CNS central nervous system.
Incidence rate ratios (IRR) and 95% confidence intervals (CI) for leukaemia, lymphoma and CNS tumours in teenagers and young adults, 1996–2005
| Leukaemia | Lymphoma | CNS Tumours b | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Model a | Variables | IRR | 95% CI | P-value | IRR | 95% CI | P-value | IRR | 95% CI | P-value |
| A | Population Mixing |
|
|
| 0.94 | 0.87-1.01 | 0.086 | 0.81 | 0.74-0.89 | <0.001 |
| B | Population Mixing | 0.93 | 0.83-1.04 | 0.222 |
|
|
|
|
|
|
| Deprivation Score | 0.99 | 0.98-1.00 | 0.114 |
|
|
|
|
|
| |
| C | Population Mixing | 0.95 | 0.84-1.07 | 0.446 | 0.97 | 0.90-1.06 | 0.529 | 0.82 | 0.74-0.91 | <0.001 |
| Deprivation Score | 0.99 | 0.98-1.01 | 0.609 | 0.97 | 0.96-0.98 | <0.001 | 0.97 | 0.95-0.99 | 0.001 | |
| Population Densityc | 1.00 | 0.99-1.00 | 0.433 | 1.00 | 1.00-1.00 | 0.820 | 1.00 | 0.99-1.00 | 0.675 | |
| D | Population Mixing | |||||||||
| 1st Decile | 0.93 | 0.73-1.19 | 0.572 | 0.97 | 0.83-1.14 | 0.689 | 1.35 | 1.13-1.61 | 0.001 | |
| 2-9th Decile | 1 | - | - | 1 | - | - | 1 | - | - | |
| 10th Decile | 0.9 | 0.77-1.05 | 0.168 | 0.98 | 0.89-1.09 | 0.718 | 0.93 | 0.81-1.06 | 0.267 | |
|
|
|
|
| |||||||
| Deprivation Score | 0.99 | 0.98-0.99 | 0.163 | 0.97 | 0.96-0.98 | <0.001 | 0.97 | 0.96-0.98 | <0.001 | |
aBest fitting model is highlighted in bold for each diagnostic group, model fit statistics are given in Table 4.
bAnalysis for main CNS tumour subgroups are shown in Table 3.
cPerson-weighted population density.
Incidence rate ratios (IRR) and 95% confidence intervals (CI) for main subgroups of leukaemia, lymphoma and CNS tumours in teenagers and young adults, 1996-2005
| Diagnostic subgroup | Multivariable model variables | |||||
|---|---|---|---|---|---|---|
| Population mixing | Deprivation score | |||||
| IRR | 95% CI |
| IRR | 95% CI |
| |
|
| ||||||
| Acute lymphoid leukaemia | 0.96 | 0.82-1.13 | 0.658 | 0.99 | 0.97-1.01 | 0.149 |
| Acute myeloid leukaemia | 0.88 | 0.73-1.06 | 0.168 | 0.99 | 0.97-1.01 | 0.474 |
| Chronic myeloid leukaemia | 0.97 | 0.71-1.34 | 0.862 | 1.01 | 0.98-1.05 | 0.497 |
| Other leukaemia | 0.89 | 0.59-1.34 | 0.575 | 0.95 | 0.91-1.00 | 0.074 |
|
| ||||||
| Non-Hodgkin lymphoma | 1.02 | 0.90-1.16 | 0.710 | 0.98 | 0.97-1.00 | 0.038 |
| Hodgkin lymphoma | 0.94 | 0.86-1.03 | 0.204 | 0.96 | 0.95-0.97 | <0.001 |
|
| ||||||
| Astrocytoma | 0.83 | 0.71-0.98 | 0.025 | 0.98 | 0.96-1.00 | 0.069 |
| Other Glioma | 0.77 | 0.57-1.03 | 0.076 | 0.96 | 0.92-0.99 | 0.026 |
| Ependymoma | 0.97 | 0.65-1.44 | 0.863 | 0.96 | 0.91-1.01 | 0.092 |
| Medulloblastoma | 1.10 | 0.75-1.60 | 0.625 | 0.96 | 0.92-1.01 | 0.107 |
| Other CNS tumoursa | 0.79 | 0.69-0.91 | 0.001 | 0.97 | 0.95-0.99 | <0.001 |
aIncludes groups 3.5 and 3.6. from Birch Classification Scheme [24].
Comparison of models shown in Table 2
| Models | Likelihood ratio test | AIC | Model choice | |
|---|---|---|---|---|
|
| Model 1 | Model 2 | ||
| Leukaemia | ||||
| A and B | 0.112 | 6900.5 | 6899.942 | A |
| B and C | 0.428 | 6899.9 | 6901.32 | |
| B and D | 0.503 | 6899.9 | 6901.33 | |
| Lymphoma | ||||
| A and B | <0.001 | 11930 | 11887.95 | B |
| B and C | 0.819 | 11888 | 11889.90 | |
| B and D | 0.574 | 11888 | 11890.32 | |
| CNS Tumours | ||||
| A and B | <0.001 | 8901.00 | 8882.79 | B |
| B and C | 0.676 | 8882.79 | 8884.61 | |
| B and D | 0.168 | 8882.79 | 8887.68 | |